- Companies
- Clearsense
Clearsense Funding, Investors & Competitors
Clearsense has raised $101M across 3 funding rounds, most recently a $50M Series D in January 2023.
Last Clearsense funding round
$50M
Series D · Jan 2023
Cumulative funding Clearsense raised
$101M
across 3 funding rounds
Key investors in Clearsense
Health Catalyst Capital
HealthQuest Capital
UPMC Enterprises
About Clearsense
Clearsense is a Jacksonville, Florida-based healthcare data platform that helps hospitals, providers, and payers manage, govern, and analyze clinical, operational, and financial data. Its Clearsense Data Management Platform and DataHub automate data curation, preparation, normalization, and governance, giving healthcare organizations real-time insight into their operations and breaking down silos between systems. The company has also added predictive modeling capabilities to help clinicians and analysts test hypotheses and act on data more quickly.
Founded
2013
HQ
Website
Status
Privately held
Customer focus
B2B
Revenue model
Subscription
Clearsense Funding History
Clearsense has raised a total of $101M across 3 funding rounds.
Clearsense's first fundraising round was a $21M undisclosed-stage round in November 2018. The most recent completed round was a $50M Series D in January 2023.
Clearsense funding rounds
| Date | Stage | Investors | Raised | Deal Summary |
|---|---|---|---|---|
| Jan 2023 | Series D | HealthQuest Capital (lead); UPMC Enterprises; Health Catalyst Capital | $50M | Clearsense, a Jacksonville, Florida-based PaaS company, partners with healthcare organizations to increase data value, governance, and transparency through its 1Clearsense Data Management Platform. The platform aims to unlock the full potential of healthcare data by delivering solutions that empower data confidence and enable data-driven decision-making for better outcomes. On January 31, 2023, Clearsense announced the successful close of a $50 million Series D funding round led by HealthQuest Capital, with participation from existing investors Health Catalyst Capital and UPMC Enterprises. Piper Sandler served as the sole placement agent and financial advisor. The funding is intended to support Clearsense's growth in 2023 by investing in infrastructure, technology, and personnel to expand the platform and promote data literacy in healthcare. CEO Gene Scheurer highlighted the investment's role in strengthening the company's mission to transform healthcare through improved trust in enterprise data and expanded data-driven operations. HealthQuest Capital, a San Francisco Bay Area-based growth capital firm managing over $1.6 billion, focuses on commercial-stage healthcare companies optimizing outcomes and reducing costs across medical technologies, diagnostics, digital health, and services. Clearsense had previously raised $30 million in 2021, bringing total funding to approximately $127.88 million across 11 rounds as of 2024. |
| Mar 2021 | Undisclosed stage | Health Catalyst Capital (lead) | $30M | Clearsense is an advanced data management and analytics technology platform serving the healthcare industry, providing a scalable data platform that enables real-time insights into clinical, operational, and financial metrics. On March 25, 2021, the company closed $30 million in financing led by Health Catalyst Capital, with funds allocated to build out its technology and advisory services to lead enterprise data strategies, including development of the Clearsense DataHub for automating data curation, preparation, normalization, and governance. The investment was highlighted as timely amid healthcare's need to streamline data access and usage, accelerated by COVID-19, where Clearsense's adaptable platform supports providers and payers by breaking industry silos and enabling efficiencies, insights, cost-savings, transparency, and value-based analytics. It operates as an adjunctive solution within any technology landscape, enhancing existing investments. Health Catalyst Capital praised Clearsense's 2020 innovations and resilience, expressing excitement for its advancements in healthcare data maturity. Subsequent rounds include a $50 million Series D in 2023 led by HealthQuest Capital with participation from Health Catalyst Capital and UPMC Enterprises, and further Series D extensions totaling over $127 million raised across 11 rounds as of 2024. |
| Nov 2018 | Undisclosed stage | - | $21M | - |
Who has invested in Clearsense?
3 investors have backed Clearsense across its funding rounds, including Health Catalyst Capital, HealthQuest Capital and UPMC Enterprises.
Lead investors include HealthQuest Capital and Health Catalyst Capital.
Clearsense Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 2 | Lead | Mar 2021 | ||
This data is available for Pro users. Sign up to see all 3 Clearsense investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAcquisitions by Clearsense
Clearsense has acquired 1 company to date.
Last acquisition by Clearsense was on September 22nd 2021. Clearsense acquired Compellon for undisclosed valuation.
Latest Acquisitions by Clearsense
| Description | Compellon is a Boston-based prescriptive analytics platform leveraging AI to deliver optimization recommendations in real-time. The software analyzes complex datasets for retail, manufacturing, and logistics, identifying actions that boost revenue by up to 15 percent. Compellon deploys on-premises or cloud, serving Fortune 500 firms with no-code interfaces for business users, focusing on supply chain and pricing decisions. |
| HQ Country | |
| HQ City | Los Angeles, CA |
| Deal Date | 22 Sep 2021 |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Clearsense acquisitions and their M&A valuation multiples. Start Free Trial | |
Clearsense Competitors
Clearsense competitors include listed companies like Claritev, GE HealthCare, United Imaging and Glaukos, and private ones like Uptake Technologies and Commure.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Publicly listed | $965M | $466M | $538M | 5.2x | ||
| Private | $100M | - | $2.3B | 23.0x | ||
| Publicly listed | $21B | $3.7B | $29B | 1.8x | ||
| Publicly listed | $2.1B | $367M | $12B | 4.8x | ||
| Publicly listed | $507M | ($157M) | $9.5B | 14.6x | ||
| Private | $200M | - | $7B | 35.0x |
Clearsense Public Comps
Clearsense is still privately-owned, but its public comps include Palantir, ServiceNow, Datadog, RELX, Strategy, IQVIA, Veeva, IDEXX Laboratories, Roper Technologies and GE HealthCare.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $4.5B | $1.5B | 92.6x | 58.1x | 285.0x | 97.4x | |||
| $13B | $2.6B | 11.1x | 9.6x | 57.2x | 25.0x | |||
| $3.4B | ($588K) | 23.6x | 19.4x | (137813.0x) | 77.6x | |||
| $13B | $4.9B | 5.5x | 5.3x | 14.4x | 13.2x | |||
| $477M | ($5.4B) | 149.4x | 144.4x | (13.1x) | (12.3x) | |||
| $16B | $3.4B | 3.6x | 3.4x | 17.2x | 14.8x | |||
| $3.2B | $965M | 11.1x | 10.2x | 36.9x | 22.4x | |||
| $4.3B | $1.5B | 9.5x | 8.9x | 27.1x | 24.9x | |||
This data is available for Pro users. Sign up to see all Clearsense competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Clearsense
| When was Clearsense founded? | Clearsense was founded in 2013. |
| Where is Clearsense headquartered? | Clearsense is headquartered in Jacksonville, FL, United States. |
| Is Clearsense publicly listed? | No, Clearsense is a private, VC-backed company. |
| How much funding has Clearsense raised? | Clearsense has raised $101M across 3 funding rounds. |
| What was Clearsense's last funding round? | Clearsense's last funding round was a $50M Series D in January 2023, led by HealthQuest Capital. |
| Who are Clearsense's investors? | Clearsense's investors include Health Catalyst Capital, HealthQuest Capital and UPMC Enterprises. |
| Which companies are comparable to Clearsense? | Companies comparable to Clearsense include Claritev, Uptake Technologies, GE HealthCare, United Imaging, Glaukos and Commure. |
| How many companies has Clearsense acquired? | Clearsense has acquired 1 company, including Compellon. |
See companies similar to Clearsense
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




